Natco Pharma Ltd. (NATCOPHARM)
Market Closed
5 Aug, 22:00
MSE XNSE Primary MSE ₹
917. 70
+0.4
+0.0436%
₹
- Market Cap
13.93 P/E Ratio
5% Div Yield
168,063 Volume
0 Eps
₹ 917.3
Previous Close Want to track NATCOPHARM and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Natco Pharma Ltd. (NATCOPHARM) Statistics
Valuation metrics
Market Cap -
Enterprise value 155.87B
Trailing P/E (ttm) 11.58
Forward P/E -
PEG ratio -0.47
Price/Sales (ttm) 4.03
Price/Book (mrq) 1.78
Enterprise Value/Revenue 3.82
Enterprise Value/EBITDA 8.99
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 25.3K
Average volume (90 days) 60.45K
Price summary
52-Week low 789.3
52-Week high 1,226.1
Beta -
50-Day moving average 925.77
200-Day moving average 972.88
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate 5
Trailing annual dividend yield 0.0055%
5-Year annual dividend yield -
Payout ratio 0.03
Dividend Date 26 Feb 2026
Ex-Dividend Date 18 Feb 2026
Last split factor 5:1
Last split Date 26 Nov 2015
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin 0.35%
Operating margin 0.3%
Operational effectiveness
Return on assets 0.13%
Return on equity 0.17%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 227.74
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) 79.21
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 118.89
Total debt (mrq) -
Total Debt/Equity (mrq) 0.08
Current ratio (mrq) 3.01%
Book value per share (mrq) 514.92
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
